Related Experiment Video
Updated: Jun 6, 2026
08:30
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
Glaucoma expert patient programme and ocular hypotensive treatment
Raed Amro1, Carol L Cox, Kathryn Waddington
1Accident and Emergency Department, Moorfields Eye Hospital NHS Foundation Trust, London.
British Journal of Nursing (Mark Allen Publishing)
|November 13, 2010
Summary
Expert patient programmes (EPPs) improve chronic disease management. The Glaucoma Expert Patient Programme (GEPP) was developed to enhance self-management for chronic open angle glaucoma (COAG) patients, improving their daily condition management.
Area of Science:
- Ophthalmology
- Health Sciences
- Patient Education
Background:
- Expert patient programmes (EPPs) are crucial for chronic disease management and patient outcomes.
- Chronic open angle glaucoma (COAG) necessitates lifelong patient management.
- No existing EPPs specifically address the needs of chronic eye conditions like COAG.
Purpose of the Study:
- To develop and implement the Glaucoma Expert Patient Programme (GEPP).
- To improve glaucoma patients' knowledge, self-management skills, expectations, and treatment adherence.
- To provide COAG patients with enhanced tools for daily condition management.
Main Methods:
- Reviewed theoretical frameworks and models for EPP design and implementation.
- Designed the GEPP based on Kate Lorig's (2003) model.
- Implemented a glaucoma-specific educational self-management programme.
Main Results:
- The GEPP was successfully developed and implemented.
- The programme offers COAG patients a new perspective on their condition.
- Patients receive knowledge, skills, and strategies for improved daily self-management.
Conclusions:
- The GEPP is a novel, glaucoma-specific educational programme.
- This programme empowers COAG patients to better manage their condition.
- EPPs can be tailored to specific chronic eye conditions for improved patient outcomes.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...